Clincosm LogoSign in Get a demo

Pulmonary Disease, Chronic Obstructive

Showing 1 - 25 of 876
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Disease, Chronic Obstructive Trial in Cambridge (GSK3862995B, Placebo)

Not yet recruiting
  • Pulmonary Disease, Chronic Obstructive
  • Cambridge, United Kingdom
    GSK Investigational Site
Nov 26, 2023

COPD Exacerbation Acute, COPD With Acute Lower Respiratory Infection, Rhinovirus Trial (Vapendavir, Placebo)

Not yet recruiting
  • COPD Exacerbation Acute
  • +35 more
  • (no location specified)
Nov 20, 2023

Pulmonary Fibrosis, Pulmonary Disease, Chronic Obstructive Trial in Québec, Lomme (Functional capacity tests)

Not yet recruiting
  • Pulmonary Fibrosis
  • Pulmonary Disease, Chronic Obstructive
  • Functional capacity tests
  • Québec, Canada
  • +1 more
Nov 6, 2023

Pulmonary Disease, Chronic Obstructive Trial in Beijing, Shenzhen, Shanghai (611 300 mg Q2W, 611 450 mg Q2W, Matching )

Not yet recruiting
  • Pulmonary Disease, Chronic Obstructive
  • 611 300 mg Q2W
  • +2 more
  • Beijing, Beijing, China
  • +2 more
Oct 25, 2023

Pulmonary Disease, Chronic Obstructive Trial in Luzhou (Digital pursed lip breathing intervention)

Not yet recruiting
  • Pulmonary Disease, Chronic Obstructive
  • Digital pursed lip breathing intervention
  • Luzhou, Sichuan, China
    The Affiliated Hospital of Southwest Medical University
Sep 30, 2023

Asthma, Breast Tumors, Coronary Disease Trial (gp-multitool.de)

Not yet recruiting
  • Asthma
  • +6 more
  • gp-multitool.de
  • (no location specified)
Sep 24, 2023

Morbid Rates After Spiriva Chronic Obstructive Pulmonary Disease

Completed
  • Pulmonary Disease, Chronic Obstructive
    • São Paulo, Brazil
      Boehringer Ingelheim Brasil
    Sep 22, 2023

    Pulmonary Disease, Chronic Obstructive Trial in Anqing (Tai-chi exercise)

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • Tai-chi exercise
    • Anqing, Anhui, China
      Anqing Hospital Affiliated to Anhui Medical University
    Aug 12, 2023

    Chronical Illness-related Limitations of Ability to Cope With

    Not yet recruiting
    • Coronary Disease
    • +15 more
      • (no location specified)
      Jul 17, 2023

      Pulmonary Disease, Chronic Obstructive Trial in Brussels (LABA, LAMA)

      Completed
      • Pulmonary Disease, Chronic Obstructive
      • Brussels, Belgium
        Erasme University Hospital
      Jun 23, 2023

      Pulmonary Disease, Chronic Obstructive Trial in Chicago (Air cleaner)

      Recruiting
      • Pulmonary Disease, Chronic Obstructive
      • Air cleaner
      • Chicago, Illinois
        Jesse Brown Veterans Affairs Medical Center
      Jun 13, 2023

      Pulmonary Disease, Chronic Obstructive, Health-Related Quality Of Life, Dyspnea Trial in Ordu, Malatya (Exercise)

      Completed
      • Pulmonary Disease, Chronic Obstructive
      • +2 more
      • Exercise
      • Ordu, Altınordu, Turkey
      • +1 more
      May 26, 2023

      Pulmonary Disease, Chronic Obstructive, Idiopathic Pulmonary Fibrosis, Asthma Trial in Seoul (HiCardi+)

      Recruiting
      • Pulmonary Disease, Chronic Obstructive
      • +2 more
      • HiCardi+
      • Seoul, Korea, Republic of
        Severance Hospital
      May 8, 2023

      Pulmonary Disease, Chronic Obstructive, Mitochondrial Alteration, Oxygen Deficiency Trial in Clermont-Ferrand (Modality of

      Recruiting
      • Pulmonary Disease, Chronic Obstructive
      • +2 more
      • Modality of exercise training
      • Clermont-Ferrand, France
        CHU de Clermont-Ferrand
      May 11, 2023

      The COPD Attack Study

      Completed
      • Pulmonary Disease, Chronic Obstructive
      • Exacerbation COPD
      • It was an observational study
      • Kampala, Uganda
      • +1 more
      Mar 21, 2023

      Patient Readmission, Pulmonary Disease, Chronic Obstructive, Heart Failure Trial in La Plata (Standard of Care, Enhanced Care)

      Not yet recruiting
      • Patient Readmission
      • +5 more
      • Standard of Care
      • Enhanced Care
      • La Plata, Maryland
        University of Maryland Charles Regional Medical Center
      Mar 14, 2023

      Pulmonary Disease, Chronic Obstructive Trial (health education, Mobile application (Creating a WhatsApp group):, Home visit:)

      Not yet recruiting
      • Pulmonary Disease, Chronic Obstructive
      • health education
      • +3 more
      • (no location specified)
      Feb 14, 2023

      Pulmonary Disease, Chronic Obstructive Trial in United States (Population-health management)

      Not yet recruiting
      • Pulmonary Disease, Chronic Obstructive
      • Population-health management
      • Minneapolis, Minnesota
      • +4 more
      Feb 6, 2023

      Pulmonary Disease, Chronic Obstructive Trial in Boston, Seattle (Rescind home oxygen order, Provider Education, Patient

      Recruiting
      • Pulmonary Disease, Chronic Obstructive
      • Rescind home oxygen order
      • +4 more
      • Boston, Massachusetts
      • +1 more
      Jan 31, 2023

      Study to Evaluate the Risk of Cardiovascular Endpoints

      Completed
      • Pulmonary Disease, Chronic Obstructive
      • Aclidinium bromide
      • Other COPD medication
      • London, United Kingdom
        Clinical Practice Research Datalink
      Jan 30, 2023

      End-tidal Carbon Dioxide asSeverity Criterion in COPD

      Not yet recruiting
      • Pulmonary Disease, Chronic Obstructive
      • Exacerbation Copd
      • End-Tidal CO2 measurement during COPD exacerbation
      • Grenoble, Isère, France
      • +1 more
      Jan 19, 2023

      Pulmonary Disease, Chronic Obstructive, Hypoxia Trial in Miami (Nocturnal Oxygen)

      Not yet recruiting
      • Pulmonary Disease, Chronic Obstructive
      • Hypoxia
      • Nocturnal Oxygen
      • Miami, Florida
        University of Miami
      Jan 18, 2023

      Symptom and Quality of Life in COPD by

      Recruiting
      • Pulmonary Disease, Chronic Obstructive
        • Nagoya, Aichi, Japan
        • +16 more
        Jan 17, 2023

        Acute Exacerbation of COPD, Corticosteroid, Morality Trial (Prednisone, Placebo)

        Not yet recruiting
        • Acute Exacerbation of COPD
        • +6 more
        • (no location specified)
        Jan 13, 2023

        Health-related Quality of Life After Switching COPD Patients

        Recruiting
        • Pulmonary Disease, Chronic Obstructive
        • Spiriva® Respimat®
        • +2 more
        • Liestal, Switzerland
          Cantonal Hosp. Baselland,Univ.Med.Dept,Liestal
        Jan 9, 2023